AstraZeneca shares fall on report of potential China probe fallout
(Reuters) -AstraZeneca shares on Tuesday recorded their worst day since March 2020 after a report that dozens of the ...
STAT1d
Probe of AstraZeneca executive in China raises questions about company’s tactics
China's investigation of AstraZeneca's top executive in the country is raising questions about the company's tactics there.
AstraZeneca says does not comment on media reports as shares slump
AstraZeneca said on Tuesday that it does not comment on speculative media reports, in response to a sharp drop in its share ...
Why Is AstraZeneca Stock Sinking On Tuesday?
Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...
Chinese authorities probing ‘dozens’ of AstraZeneca executives, Yicai reports
Chinese authorities are investigating dozens of senior AstraZeneca (AZN) China executives amid an ongoing insurance fraud case, Yicai Global ...
AstraZeneca Stock Falls on China Probe Fears
AstraZeneca shares fell 8% in London Tuesday, the biggest drop in four years following a fresh report that a Chinese investigation of the company has widened. AstraZeneca said last week that its China ...
Report finds China targeted AstraZeneca in fraud probe over cancer treatment
The pharmaceutical giant, whose China chief is now under investigation, was previously at the centre of insurance scam cases, ...
AstraZeneca Falls Most Since 2020 as China Probe Fears Mount
AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns ...